China, Nov. 16 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Efficacy of Dexmedetomidine in the Perioperative Management of Neurocognitive Dysfunction (PND) in Patients With Colorectal Tumors and Its Impact on the Gut Microbiota and Regulation of the Brain-Gut Axis'. The following are the other relevant details related to the trial:
Registration Number: ChiCTR2600136715
Registration Time: 2026/11/14
Type: Interventional study
Primary Sponsor: Jiangsu Cancer Hospital
To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=335650
Published by HT Digital Content Services with permission from Health Daily Digest....